Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ASRT Stock Summary
Top 10 Correlated ETFs
ASRT
In the News
Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
LAKE FOREST, Ill., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, today announced that it will release fourth quarter and full year 2023 financial results on Monday, March 11, 2024, after the market close. Following the release of its financial results, Assertio's management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.
Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why
Assertio (ASRT) appears weighed down by the recent leadership transition. The company is also facing challenges with sales of its product franchisee of late.
Assertio Holdings: Here's A Contrarian Opportunity In The Health Care Sector
Assertio Holdings has dropped substantially and is down more than 70% in the past year. Assertio Holdings appears to have been oversold based on quantitative factors. It trades at a very low enterprise value to revenue ratio compared to its peers. Diversification is important in managing the risk associated with distressed equities like Assertio. I'm issuing a Buy rating but suggest diversifying.
Assertio (ASRT) Shares Fall as Dan Peisert Steps Down as CEO
Assertio (ASRT) appoints Heather Mason as its interim CEO as its current CEO, Dan Peisert, steps down from his role. Shares of the company fall on the same.
Pre-Surge Penny Picks: 3 Stocks to Buy Before They Boom
Today's backdrop of a predicted fall in interest rates, as well as the expectation that indices like the S&P 500 will surge higher, has some important considerations for penny stocks. Penny stocks tend to do better when the downward pressures on their valuations subside.
Assertio Holdings Inc. (ASRT) Q3 2023 Earnings Call Transcript
Assertio Holdings Inc. (NASDAQ:ASRT ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Matt Kreps - Darrow Associates, IR Dan Peisert - President and CEO Ajay Patel - SVP & Chief Accounting Officer Paul Schwichtenberg - SVP & CFO Conference Call Participants Thomas Flaten - Lake Street Capital Markets Jim Sidoti - Sidoti Scott Henry - ROTH MKM Partners Operator Good morning and welcome to the Assertio Holdings Inc. Third Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023
LAKE FOREST, Ill., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release third quarter 2023 financial results on Wednesday, November 8, 2023, after the market close. Following the release of its financial results, Assertio's management will host a live webcast of the earnings conference call at 4:30 p.m. Eastern Time.
Assertio Holdings: Uncovering A Tapestry Of Trading Opportunities From This Oversold Ticker
Assertio Holdings has undergone a significant transformation in its business model, reducing debt and exiting the opioid business. The company's recent performance has shown strong growth, with increased net product sales and improved gross margin. Assertio's stock is currently undervalued, trading at a significant discount, and has the potential for future growth and a turnaround.
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?
Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Assertio (ASRT) Stock?
Investors need to pay close attention to Assertio (ASRT) stock based on the movements in the options market lately.
ASRT Financial details
ASRT Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.98 | 4.05 | 2.6 | 2.9 | 2.14 | |
Net income per share | -12.29 | -1.07 | -0.03 | 2.03 | -4.67 | |
Operating cash flow per share | 5.12 | -2.5 | 0.13 | 1.46 | 0.7 | |
Free cash flow per share | 5.03 | -2.5 | 0.13 | 1.45 | 0.69 | |
Cash per share | 2.38 | 0.79 | 0.86 | 1.2 | 1.03 | |
Book value per share | 3.28 | 2.12 | 2.4 | 4.19 | 1.94 | |
Tangible book value per share | -19.38 | -5.52 | -2.66 | 0.51 | 0.38 | |
Share holders equity per share | 3.28 | 2.12 | 2.4 | 4.19 | 1.94 | |
Interest debt per share | 23.17 | 3.82 | 1.96 | 1.39 | 0.6 | |
Market cap | 88.4M | 37.74M | 93.09M | 231.78M | 76M | |
Enterprise value | 397.55M | 101.06M | 129.77M | 233.71M | 43.47M | |
P/E ratio | -0.41 | -1.34 | -72.67 | 2.11 | -0.23 | |
Price to sales ratio | 0.39 | 0.36 | 0.84 | 1.48 | 0.5 | |
POCF ratio | 0.98 | -0.58 | 16.85 | 2.95 | 1.53 | |
PFCF ratio | 0.99 | -0.58 | 17.02 | 2.96 | 1.55 | |
P/B Ratio | 1.53 | 0.68 | 0.91 | 1.03 | 0.55 | |
PTB ratio | 1.53 | 0.68 | 0.91 | 1.03 | 0.55 | |
EV to sales | 1.73 | 0.95 | 1.17 | 1.5 | 0.29 | |
Enterprise value over EBITDA | 3.79 | -3.99 | 3.26 | 2.56 | 0.82 | |
EV to operating cash flow | 4.39 | -1.54 | 23.5 | 2.97 | 0.88 | |
EV to free cash flow | 4.47 | -1.54 | 23.72 | 2.98 | 0.89 | |
Earnings yield | -2.46 | -0.75 | -0.01 | 0.47 | -4.37 | |
Free cash flow yield | 1.01 | -1.74 | 0.06 | 0.34 | 0.64 | |
Debt to equity | 6.06 | 1.51 | 0.72 | 0.3 | 0.29 | |
Debt to assets | 0.67 | 0.28 | 0.23 | 0.16 | 0.14 | |
Net debt to EBITDA | 2.94 | -2.5 | 0.92 | 0.02 | -0.61 | |
Current ratio | 0.56 | 0.71 | 0.77 | 1.39 | 1.83 | |
Interest coverage | 0.05 | -2.95 | 0.92 | 7.26 | 7.38 | |
Income quality | -0.42 | 2.33 | -4.31 | 0.72 | -0.15 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | -0.15 | 0 | 0 | |
Sales general and administrative to revenue | 0.47 | 0.98 | 0.49 | 0.28 | 0 | |
Research and developement to revenue | 0.04 | 0.04 | 0 | 0 | 0.02 | |
Intangibles to total assets | 0.76 | 0.66 | 0.66 | 0.48 | 0.39 | |
Capex to operating cash flow | -0.02 | 0 | -0.01 | 0 | -0.01 | |
Capex to revenue | -0.01 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -0.01 | 0 | 0 | -0.01 | -0.02 | |
Stock based compensation to revenue | 0.05 | 0.1 | 0.03 | 0.05 | 0.06 | |
Graham number | 30.1 | 7.15 | 1.27 | 13.84 | 14.29 | |
ROIC | 0.01 | -0.2 | 0.12 | 0.7 | 0.18 | |
Return on tangible assets | -1.72 | -0.27 | -0.01 | 0.51 | -1.9 | |
Graham Net | -22.25 | -7.17 | -3.52 | -1.53 | -0.29 | |
Working capital | -80.6M | -38.43M | -31.52M | 36.95M | 77.62M | |
Tangible asset value | -342.58M | -144.57M | -113.64M | 27.73M | 26.67M | |
Net current asset value | -365.26M | -153.51M | -120.64M | -55.93M | 22.65M | |
Invested capital | 6.06 | 1.51 | 0.72 | 0.3 | 0.29 | |
Average receivables | 39.98M | 43.55M | 44.36M | 44.86M | 46.51M | |
Average payables | 11.17M | 15.5M | 10.75M | 6.34M | 9.72M | |
Average inventory | 3.4M | 7.56M | 9.6M | 10.59M | 25.69M | |
Days sales outstanding | 67.98 | 152.32 | 145.85 | 105.96 | 114.4 | |
Days payables outstanding | 621.82 | 271.99 | 154.12 | 116.64 | 88.79 | |
Days of inventory on hand | 131.02 | 215.12 | 172.66 | 266.64 | 248.98 | |
Receivables turnover | 5.37 | 2.4 | 2.5 | 3.44 | 3.19 | |
Payables turnover | 0.59 | 1.34 | 2.37 | 3.13 | 4.11 | |
Inventory turnover | 2.79 | 1.7 | 2.11 | 1.37 | 1.47 | |
ROE | -3.75 | -0.51 | -0.01 | 0.49 | -2.41 | |
Capex per share | -0.08 | 0 | 0 | -0.01 | -0.01 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.76 | 0.85 | 0.58 | 0.44 | 0.35 | |
Net income per share | 1.34 | -0.07 | 0.12 | -3.42 | -0.61 | |
Operating cash flow per share | 0.4 | 0.46 | 0.27 | 0.03 | 0.06 | |
Free cash flow per share | 0.4 | 0.45 | 0.26 | 0.03 | 0.06 | |
Cash per share | 0.98 | 1.38 | 1 | 0.94 | 0.78 | |
Book value per share | 3.42 | 5.04 | 3.62 | 2.36 | 1.46 | |
Tangible book value per share | 0.42 | 1.18 | 0.98 | 0.03 | 0.28 | |
Share holders equity per share | 3.42 | 5.04 | 3.62 | 2.36 | 1.46 | |
Interest debt per share | 1.03 | 0.8 | 0.56 | 0.5 | 0.42 | |
Market cap | 283.82M | 317.04M | 380.18M | 209.19M | 101.3M | |
Enterprise value | 285.75M | 287.06M | 348.26M | 171.16M | 68.77M | |
P/E ratio | 0.8 | -22.75 | 11.22 | -0.19 | -0.44 | |
Price to sales ratio | 5.64 | 7.47 | 9.27 | 5.87 | 3.07 | |
POCF ratio | 10.63 | 13.96 | 20.44 | 81.11 | 17.75 | |
PFCF ratio | 10.74 | 14.02 | 21.24 | 81.11 | 17.21 | |
P/B Ratio | 1.26 | 1.26 | 1.5 | 1.08 | 0.73 | |
PTB ratio | 1.26 | 1.26 | 1.5 | 1.08 | 0.73 | |
EV to sales | 5.67 | 6.76 | 8.5 | 4.8 | 2.08 | |
Enterprise value over EBITDA | 9.56 | 13.61 | 17.59 | 26.1 | -56.14 | |
EV to operating cash flow | 10.7 | 12.64 | 18.72 | 66.37 | 12.05 | |
EV to free cash flow | 10.81 | 12.7 | 19.46 | 66.37 | 11.68 | |
Earnings yield | 0.31 | -0.01 | 0.02 | -1.34 | -0.57 | |
Free cash flow yield | 0.09 | 0.07 | 0.05 | 0.01 | 0.06 | |
Debt to equity | 0.3 | 0.15 | 0.15 | 0.21 | 0.29 | |
Debt to assets | 0.16 | 0.09 | 0.09 | 0.1 | 0.14 | |
Net debt to EBITDA | 0.06 | -1.42 | -1.61 | -5.8 | 26.55 | |
Current ratio | 1.39 | 1.46 | 1.68 | 1.62 | 1.83 | |
Interest coverage | 16.55 | 13.02 | 16.54 | -303.55 | -8.12 | |
Income quality | 0.3 | -6.52 | 2.2 | -0.01 | -0.1 | |
Dividend Yield | 0 | 0 | 0.04 | 0 | 0 | |
Payout ratio | 0 | 0 | 1.93 | 0 | 0 | |
Sales general and administrative to revenue | 0.2 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0.01 | 0.04 | 0.03 | |
Intangibles to total assets | 0.48 | 0.46 | 0.46 | 0.5 | 0.39 | |
Capex to operating cash flow | -0.01 | 0 | -0.04 | 0 | 0.03 | |
Capex to revenue | -0.01 | 0 | -0.02 | 0 | 0.01 | |
Capex to depreciation | -0.03 | -0.02 | -0.11 | 0 | 0.04 | |
Stock based compensation to revenue | 0.05 | 0.06 | 0.05 | 0.05 | 0.08 | |
Graham number | 10.16 | 2.82 | 3.14 | 13.48 | 4.46 | |
ROIC | 0.77 | 0.03 | 0.03 | -1.19 | -0.06 | |
Return on tangible assets | 0.41 | -0.02 | 0.04 | -1.47 | -0.33 | |
Graham Net | -1.25 | -1.05 | -0.57 | -0.51 | -0.22 | |
Working capital | 36.95M | 43.3M | 54.07M | 70.67M | 77.62M | |
Tangible asset value | 27.73M | 58.95M | 68.84M | 2.6M | 26.67M | |
Net current asset value | -55.93M | -25.76M | -17.36M | -2.2M | 22.65M | |
Invested capital | 0.3 | 0.15 | 0.15 | 0.21 | 0.29 | |
Average receivables | 45.02M | 45.91M | 44.04M | 52.04M | 55.07M | |
Average payables | 7.18M | 6.08M | 8.68M | 15.09M | 16.22M | |
Average inventory | 13.98M | 14.96M | 17.52M | 30.76M | 40.2M | |
Days sales outstanding | 81.07 | 98.48 | 91.35 | 157.8 | 130.05 | |
Days payables outstanding | 89.64 | 101.62 | 210.89 | 242.26 | 82.68 | |
Days of inventory on hand | 204.93 | 267.12 | 354.89 | 544.46 | 231.87 | |
Receivables turnover | 1.11 | 0.91 | 0.99 | 0.57 | 0.69 | |
Payables turnover | 1 | 0.89 | 0.43 | 0.37 | 1.09 | |
Inventory turnover | 0.44 | 0.34 | 0.25 | 0.17 | 0.39 | |
ROE | 0.39 | -0.01 | 0.03 | -1.45 | -0.42 | |
Capex per share | 0 | 0 | -0.01 | 0 | 0 |
ASRT Frequently Asked Questions
What is Assertio Holdings, Inc. stock symbol ?
Assertio Holdings, Inc. is a US stock , located in Lake forest of Il and trading under the symbol ASRT
What is Assertio Holdings, Inc. stock quote today ?
Assertio Holdings, Inc. stock price is $0.9593 today.
Is Assertio Holdings, Inc. stock public?
Yes, Assertio Holdings, Inc. is a publicly traded company.